Antisense Technology
A 2'-succinyl linker provides oligonucleotides new conduits for conjugation
Published in Gene Therapy Weekly, April 8th, 2004
According to a study from Austria, "conjugation of ligands to antisense oligonucleotides is a promising approach for enhancing their effects. In this report, a new method for synthesizing oligonucleotide conjugates is described. 2'-Amino-2'-deoxy-5'-dimethoxytrityl-uridine was selectively acylated with a succinic acid linker at the 2' position."
"This compound was incorporated at the 3' end of an oligonucleotide corresponding to the sequence of Oblimersen. The carboxyl group was protected for oligonucleotide synthesis as a benzyl ester, which could be selectively cleaved at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-04-08)
More Articles from Gene Therapy Weekly
- Immunology
CpG oligonucleotides elicit antitumor responses in melanoma models - Oncology
Double-ablated adenovirus has an affinity with tumor targets - Antimicrobial Therapy
Antioxidant gene therapy protects hearing against antibiotic-mediated injury - Hematology
Erythrocyte ghosts prolong plasmid DNA expression in the blood - Neuroscience
Bone marrow cells guide brain-derived neurotrophic factor genes into the brain - Ophthalmology
In utero gene delivery prevents congenital blindness in murine pups - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
